Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 820-825

  Norin, Stefan ^b   Kimby, Eva ^b   Lundin, Jeanette ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic lymphocytic leukemia; CT scan; Subcutaneous

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SPLENOMEGALY; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; MALE; NEOPLASM STAGING; PALPATION; PROGNOSIS; RETROSPECTIVE STUDIES; SPLEEN; SPLENOMEGALY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77956923749     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9292-y     Document Type: Article

References (21)

1. KR Rai, et al. 1975 Clinical staging of chronic lymphocytic leukemia Blood 46 219 234 1:STN:280:DyaE2M7osVCksA%3D%3D 1139039
2. JL Binet, et al. 1981 A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Cancer 48 198 206 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V 1:STN:280:DyaL3M3gvFyhtg%3D%3D 7237385 (Pubitemid 11064396)
3. KR Rai T Han 1990 Prognostic factors and clinical staging in chronic lymphocytic leukemia Hematol Oncol Clin North Am 4 447 456 1:STN:280: DyaK3c3hs1CrsA%3D%3D 2182601
4. M Hallek, et al. 2008 Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines Blood 111 5446 5456 10.1182/blood-2007-06-093906 1:CAS:528:DC%2BD1cXnsVOktrk%3D 18216293
5. BH Mavromatis BD Cheson 2002 Pre- and post-treatment evaluation of non-Hodgkin's lymphoma Best Pract Clin Haematol 15 429 447 10.1053/beha.2002. 0217 10.1053/beha.2002.0217
6. CR Isasi P Lu MD Blaufox 2005 A metaanalysis of 18F-2-deoxy-2-fluoro-D- glucose positron emission tomography in the staging and restaging of patients with lymphoma Cancer 104 1066 1074 10.1002/cncr.21253 10.1002/cncr.21253 16047335 (Pubitemid 41170236)
7. J Lundin, et al. 2002 Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL) Blood 100 3 768 773 10.1182/blood-2002-01-0159 10.1182/blood-2002-01-0159 1:CAS:528: DC%2BD38XlvVCltrg%3D 12130484 (Pubitemid 34832599)
8. K Karlsson, et al. 2002 Oral cladribine for B-cell chronic lymphocytic leukemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously treated patients Br J Haematol 116 538 548 10.1046/j.0007-1048.2001.03296.x 10.1046/j.0007-1048.2001.03296.x 1:CAS:528:DC%2BD38XislSns78%3D 11849209 (Pubitemid 34178652)
9. G Juliusson J Liliemark 1996 Long-term survival following cladribine (2-chlorodeoxyadenosine) therapy in previously treated patients with chronic lymphocytic leukemia Ann Oncol 4 373 379
10. A Osterborg, et al. 1997 Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H treatment in chronic lymphocytic leukemia J Clin Oncol 15 1567 1574 1:STN:280:DyaK2szjs1KjtQ%3D%3D 9193354
11. G Juliusson, et al. 1996 Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukaemia J Clin Oncol 14 2160 2166 1:CAS:528:DyaK28XksFejt7c%3D 8683250 (Pubitemid 26230120)
12. BD Cheson, et al. 1996 National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: revised guidelines for diagnosis and treatment Blood 87 12 4990 4997 1:CAS:528:DyaK28XjsFGisb8%3D 8652811
13. BD Cheson, et al. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol 17 1244 1253 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
14. P Solal-Celigny, et al. 1993 Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in advanced follicular lymphoma N Engl J Med 329 1608 1614 10.1056/NEJM199311253292203 10.1056/NEJM199311253292203 1:STN:280:DyaK2c%2FkvF2qug%3D%3D 8232429 (Pubitemid 23345639)
15. P Moreton, et al. 2005 Eradication of minimal residual disease in B-cell chronic lymphocytic leukaemia after alemtuzumab therapy is associated with prolonged survival J Clin Oncol 23 2971 2979 10.1200/JCO.2005.04.021 10.1200/JCO.2005.04.021 1:CAS:528:DC%2BD2MXkslGhu78%3D 15738539 (Pubitemid 46224116)
16. AC Rawstron, et al. 2007 International standardized approach for flow cytometric monitoring in chronic lymphocytic leukaemia Leukemia 21 956 964 1:STN:280:DC%2BD2s3ks1aquw%3D%3D 17361231
17. BF Eichhorst, et al. 2006 Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia Blood 107 885 891 10.1182/blood-2005-06-2395 10.1182/blood-2005-06-2395 1:CAS:528:DC%2BD28Xht1OnsLc%3D 16219797 (Pubitemid 43156283)
18. A Muntañola, et al. 2007 Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukaemia J Clin Oncol 25 1576 1580 10.1200/JCO.2006.08.4194 10.1200/JCO.2006.08.4194 17353549 (Pubitemid 46733085)
19. Maslak P, Caravelli J, Alban A, Chanan-Khan A. Complete remission in chronic lymphocytic leukemia (CLL) is strongly affected by the use of CT scanning: Results from a prospective randomized trial of fludarabine plus cyclophosphamide (Flu/Cy) with or without genasense (Oblimersen) in patients with relapsed or refractory disease. Blood 2006;108. ASH (Abstr nr 2834).
20. Bosch F, et al. Computed tomography (CT) predicts response duration in patients with chronic lymphocytic leukemia (CLL) in complete response (CR) by conventional, NCI-working group, criteria. Blood 2006;108. ASH (Abstr nr 2835).
21. KA Blum, et al. 2007 Computed tomography scans do not improve the predictive power of 1996 National Cancer Institute-sponsored working group chronic lymphocytic leukaemia response criteria J Clin Oncol 25 5624 5629 10.1200/JCO.2007.12.1152 10.1200/JCO.2007.12.1152 17984187